Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?
Veysel Tahan, Reşat Özaras, Çetin Karaca, Süleyman Uraz, Fatih Eren, Ahmet Danalıoğlu, Erol Avşar, Salih Türkoğlu, Kenan Midilli, Fehmı Tabak, Recep Öztürk, Ali Mert, Hakan Şentürk, Nurdan Tözün
PubMed, 2009
Abstract
This research paper explore the methodology and findings associated with PubMed. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).